Cargando…
Vaccine platform recombinant measles virus
The classic development of vaccines is lengthy, tedious, and may not necessarily be successful as demonstrated by the case of HIV. This is especially a problem for emerging pathogens that are newly introduced into the human population and carry the inherent risk of pandemic spread in a naïve populat...
Autor principal: | Mühlebach, Michael D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7089060/ https://www.ncbi.nlm.nih.gov/pubmed/28710608 http://dx.doi.org/10.1007/s11262-017-1486-3 |
Ejemplares similares
-
Versatility of live-attenuated measles viruses as platform technology for recombinant vaccines
por: Ebenig, Aileen, et al.
Publicado: (2022) -
Development of Recombinant Measles Virus-Based Vaccines
por: Mühlebach, Michael D., et al.
Publicado: (2016) -
Reverse Genetics of Measles Virus and Resulting Multivalent Recombinant Vaccines: Applications of Recombinant Measles Viruses
por: Billeter, M. A., et al.
Publicado: (2009) -
93. Novel recombinant measles virus vaccine prevents measles virus disease in rhesus macaques
por: Rubens, Jessica, et al.
Publicado: (2022) -
Evidence of recombination among early-vaccination era measles virus strains
por: Schierup, Mikkel H, et al.
Publicado: (2005)